Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Nearer-Term Availability Survodutide Phase 3 SYNCHRONIZE trials fully enrolled with results expected H1 2026, potentially positioning survodutide for regulatory submission before retatrutide Phase 3 data matures
3 That third receptor glucagon is what makes retatrutide different, and potentially more powerful, than anything currently available
WHO MAY BE A GOOD CANDIDATE FOR GLP-1 OR GIP THERAPY
The best choice depends on your BMI , medical history , and ability to maintain long-term lifestyle changes under professional guidance
Insulin resistance the bodys impaired ability to use insulin effectivelyplays a central role in both of these conditions
US$ 27.24
US$ 22.75
US$ 24.31
US$ 24.00
US$ 23.17
US$ 29.79
US$ 29.77
US$ 26.11
US$ 25.61
